1,673 material Form 8-K filings that 1,260 companies we cover made with the SEC in February 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
FTI Consulting reported record fourth-quarter 2025 revenue of $990.7 million, up 10.7%, and full-year revenue of $3.789 billion, up 2.4%. Fourth-quarter EPS rose to $1.78 from $1.38 despite a $0.38 per-share charge for a valuation allowance on prior-year foreign deferred tax assets, and the company introduced 2026 guidance of $3.940 billion to $4.100 billion in revenue and $8.90 to $9.60 in EPS.
Q4 2025 revenue of $990.7 million, up from $894.9 million; diluted EPS of $1.78 versus $1.38 a year earlier
Full-year 2025 diluted EPS of $8.24 versus $7.81; full-year net income of $270.9 million versus $280.1 million
2026 guidance: revenue of $3.940 billion to $4.100 billion and EPS of $8.90 to $9.60
Repurchased $858.6 million of common stock in 2025; about $491.8 million remained under the buyback program at December 31, 2025
Monolithic Power Systems said its audit committee concluded that its 2024 annual financial statements and its 2025 quarterly statements should no longer be relied upon because of an unintentional error in accounting for deferred income taxes tied to a one-time foreign tax incentive. The restatement cuts 2024 net income by $194.6 million to $1.592 billion, while 2025 net income rises $5.6 million, and the company says revenue, its non-GAAP measures and its Q1 2026 outlook are unchanged.
2024 net income restated to $1.592 billion from $1.787 billion; diluted EPS restated to $32.60 from $36.59.
The error relates to deferred income taxes on a one-time tax incentive granted by a foreign jurisdiction; the company says it is non-cash and involved no misconduct.
2025 net income increases $5.6 million to $621.5 million; diluted EPS rises to $12.86 from $12.75.
Revenue and non-GAAP measures are unaffected, and the Q1 2026 business outlook from February 5, 2026 is unchanged; the 2025 Form 10-K will be filed immediately after this 8-K.
DTE Energy furnished audited 2025 financial statements for its indirect subsidiary DTE Gas Company, which show higher revenue and net income than in 2024. The filing is a subsidiary disclosure and does not change DTE Energy's own guidance, but it shows the gas utility's growth and a pending rate request that could raise its base rates.
Operating revenues were $2,033 million in 2025, up $250 million from $1,783 million in 2024, mainly from weather ($119 million) and gas cost recovery ($111 million).
Net income was $296 million in 2025, compared with $259 million in 2024; operating income was $498 million, compared with $438 million.
DTE Gas filed a rate case on November 13, 2025, requesting a net base rate increase of $163 million and a return on equity increase from 9.8% to 10.25%; a final MPSC order is expected in September 2026.
PricewaterhouseCoopers LLP issued an unqualified audit opinion dated February 27, 2026.
Saul Centers reported fourth-quarter 2025 total revenue of $75.1 million, up from $67.9 million a year earlier, while net income fell to $8.2 million from $10.4 million. Net income available to common stockholders dropped to $3.7 million, or $0.15 per share, from $5.3 million, or $0.22 per share, which the company attributes mainly to the start of operations at its Hampden House property.
Q4 2025 total revenue was $75.1 million, compared with $67.9 million in Q4 2024.
Q4 2025 net income available to common stockholders was $3.7 million, or $0.15 per diluted share, versus $5.3 million, or $0.22, a year earlier.
Hampden House, which opened October 1, 2025, reduced Q4 net income by $5.1 million, including a $2.8 million reduction in capitalized interest.
Funds from operations available to common stockholders and noncontrolling interests were $21.5 million, or $0.61 per share, versus $22.0 million, or $0.63, a year earlier.
HEI reported full-year 2025 net income of $123 million, or $0.71 per diluted share, compared with a net loss of $1,426 million, or $11.23 per share, in 2024, when a $1,875 million Maui wildfire tort-related provision was recorded. Excluding wildfire and strategic review costs, core income from continuing operations rose to $149 million, but core diluted EPS fell to $0.86 from $0.98, and full-year total revenues declined to $3,086.9 million from $3,219.9 million.
Full-year 2025 net income was $123 million, or $0.71 per diluted share, versus a net loss of $1,426 million, or $11.23 per share, in 2024.
Full-year 2025 core income from continuing operations was $149 million, or $0.86 per share, compared with $124 million, or $0.98 per share, in 2024.
Fourth quarter 2025 net income was $40 million, or $0.23 per share, compared with a net loss of $68 million, or $0.40 per share, in the fourth quarter of 2024.
Full-year 2025 total revenues were $3,086.9 million, compared with $3,219.9 million in 2024.
Where Food Comes From reported fourth-quarter and full-year 2025 results, with revenue and profit both lower than in 2024. Full-year total revenue fell to $24.9 million from $25.7 million and diluted EPS fell to $0.30 from $0.40, while the fourth quarter swung to a net loss. The filing furnishes the February 26, 2026 earnings press release and conference call transcript, which attribute the decline mainly to lower beef-related verification activity.
Full-year 2025 total revenue was $24.9 million vs. $25.7 million in 2024; diluted EPS was $0.30 vs. $0.40.
Fourth-quarter 2025 net loss of $0.2 million ($0.04 per diluted share) vs. net income of $1.0 million ($0.18) a year earlier.
Full-year net income included a $946,000 gain on sale of assets; cash from operations was $1.6 million vs. $2.7 million.
The company bought back 183,016 shares in 2025 and expects to continue repurchasing stock in 2026.
National HealthCare Corporation reported results for the year and quarter ended December 31, 2025, in a press release furnished under Item 2.02. Full-year net operating revenues and grant income rose 16.1% to $1.5 billion, and GAAP net income attributable to NHC rose to $120.0 million from $101.9 million. For shareholders, both revenue and reported profit increased, though the filing notes that the year's GAAP results include unrealized gains on marketable equity securities.
FY2025 net operating revenues and grant income: $1,517,781,000, up from $1,307,382,000 in 2024
FY2025 GAAP net income attributable to NHC: $120,015,000 (diluted EPS $7.67), up from $101,927,000 in 2024
FY2025 adjusted diluted EPS: $6.65, compared with $4.93 in 2024
Q4 2025 GAAP diluted EPS: $1.58, compared with $0.39 in Q4 2024; Q4 adjusted diluted EPS: $1.83, compared with $1.66
Arbor Realty Trust reported fourth-quarter 2025 net income of $14.6 million, or $0.07 per diluted share, down from $59.8 million, or $0.32, a year earlier. Full-year net income was $107.4 million, or $0.56 per diluted share, versus $1.18 in 2024. The board declared a $0.30 quarterly dividend, down from $0.43 declared in the fourth quarter of 2024.
Q4 2025 net income of $14.6 million, or $0.07 per diluted share, versus $0.32 in Q4 2024
Q4 2025 distributable earnings of $41.2 million, or $0.19 per diluted share, versus $0.40 in Q4 2024
Full-year 2025 net income of $107.4 million, or $0.56 per diluted share, versus $1.18 in 2024
Dividend of $0.30 per share payable March 24, 2026 to holders of record on March 10, 2026
Assured Guaranty Ltd. filed audited 2025 combined financial statements for its subsidiary Assured Guaranty Inc. and posted them on its website, along with a financial supplement and a fixed income investor presentation. The subsidiary reported total revenues of $806 million for 2025, up from $668 million in 2024, and net income attributable to Assured Guaranty Inc. of $437 million, up from $402 million. The filing covers the subsidiary only, not the parent's consolidated results.
Total revenues were $806 million in 2025, compared with $668 million in 2024.
Net income attributable to Assured Guaranty Inc. was $437 million in 2025, compared with $402 million in 2024.
Dividends paid to the parent were $287 million in 2025, compared with $400 million in 2024.
Total shareholder's equity was $5,485 million as of December 31, 2025, compared with $5,376 million a year earlier.
TransMedics added detail to its fourth-quarter 2025 results, showing that a $103.3 million release of a U.S. tax valuation allowance produced a $83.8 million net income tax benefit. At a 19.1% annual effective tax rate, fourth-quarter net income would be $17.5 million, or $0.47 per diluted share, versus the reported $105.4 million, or $2.62 per share. The company expects future quarterly tax provisions to be more in line with U.S. statutory rates.
Released $103.3 million U.S. tax valuation allowance in Q4 2025, producing an $83.8 million net income tax benefit
Reported Q4 2025 net income of $105.4 million ($2.62 per diluted share); adjusted net income of $17.5 million ($0.47 per share)
2025 annual effective tax rate was (77.0)%; excluding the release, it would have been 19.1%
Sunstone Hotel Investors reported fourth-quarter 2025 net income of $7.2 million, up from $0.8 million a year earlier, with total portfolio RevPAR up 9.6%. Full-year 2025 net income fell to $24.6 million from $43.3 million, though the company said it would have been $33.3 million excluding a loss on the June 2025 sale of the Hilton New Orleans St. Charles. The company also reauthorized a $500.0 million stock repurchase program and issued 2026 guidance.
Q4 2025 net income was $7.2 million versus $0.8 million; Adjusted EBITDA re rose 17.6% to $56.6 million.
Full-year 2025 Adjusted FFO per diluted share was $0.86, up 7.5%, and above the $0.835 midpoint of prior guidance of $0.80 to $0.87.
In February 2026 the board reauthorized repurchases of up to $500.0 million of common and preferred stock.
2026 guidance calls for net income of $21 to $46 million and Adjusted FFO per diluted share of $0.81 to $0.94.
Alpha Metallurgical Resources reported a fourth-quarter 2025 net loss of $17.3 million, or $1.34 per diluted share, compared with a $5.5 million loss in the third quarter and a $2.1 million loss a year earlier. For full-year 2025, the company posted a net loss of $61.7 million, or $4.75 per diluted share, after net income of $187.6 million in 2024, so shareholders are seeing a sharp reversal in profitability.
Q4 2025 net loss of $17.3 million ($1.34 per diluted share) vs. a $2.1 million loss in Q4 2024
Adjusted EBITDA of $28.5 million in Q4 2025, down from $41.7 million in Q3 2025 and $53.2 million in Q4 2024
Full-year 2025 total revenues of $2.13 billion vs. $2.96 billion in 2024
As of February 20, 2026, about 6.9 million shares repurchased for about $1.1 billion under a $1.5 billion authorization
CubeSmart reported fourth-quarter 2025 results on February 26, 2026, with diluted EPS down to $0.34 from $0.45 and FFO, as adjusted, per diluted share down 5.9% to $0.64. For the full year, diluted EPS fell to $1.46 from $1.72. The company also gave initial 2026 guidance of $1.55 to $1.63 in diluted EPS and $2.52 to $2.60 in FFO, as adjusted, per share, which shareholders can compare with 2025 results.
Q4 2025 net income attributable to common shareholders was $78.7 million, compared with $101.9 million in Q4 2024.
Same-store net operating income decreased 1.1% in Q4 2025, with same-store revenues down 0.1% and operating expenses up 2.9%.
2026 guidance: diluted EPS of $1.55 to $1.63 and FFO, as adjusted, per diluted share of $2.52 to $2.60; the filing does not state a prior guidance range.
TXNM Energy reported 2025 results on February 27, 2026. Electric operating revenues rose to $2.17 billion from $1.97 billion, but GAAP net earnings attributable to TXNM fell to $151.4 million from $242.2 million, and ongoing EPS dropped to $2.33 from $2.74. The company will not issue 2026 earnings guidance while its proposed $61.25-per-share acquisition by Blackstone Infrastructure is pending.
GAAP diluted EPS was $1.48 in 2025 versus $2.67 in 2024; ongoing diluted EPS was $2.33 versus $2.74.
Electric operating revenues were $2.17 billion in 2025 versus $1.97 billion in 2024.
GAAP 2025 results included a $58.8 million pension settlement charge and $43.1 million of costs related to the planned transaction.
No 2026 earnings guidance will be issued during the Blackstone transaction; closing is expected in the second half of 2026.
NIQ Global Intelligence reported fourth-quarter 2025 revenue of $1,139.1 million, up 9.2% year over year, and full-year revenue of $4,198.4 million, up 5.7%. The net loss attributable to NIQ narrowed to $32.2 million in the quarter and $353.3 million for the year, and the company introduced 2026 guidance along with a cost program that carries $50 million to $60 million of pre-tax restructuring charges.
Q4 2025 net loss attributable to NIQ was $32.2 million, compared with $172.9 million in Q4 2024.
Full-year 2025 adjusted EBITDA was $916.5 million, up 23.8%, and the adjusted EBITDA margin was 21.8%.
2026 full-year guidance calls for as-reported revenue of $4,439 million to $4,452 million and adjusted EBITDA of $1,043 million to $1,060 million.
In February 2026 the company approved a cost program expected to generate $55 million to $65 million of annualized savings by the end of 2026.
ANI Pharmaceuticals reported record fourth-quarter and full-year 2025 results, with Q4 net revenue of $247.1 million and GAAP net income available to common shareholders of $27.5 million, compared with a loss in the prior-year quarter. The company reaffirmed its full-year 2026 guidance, including total net revenue of $1,055 million to $1,115 million, which matters to shareholders as a reaffirmation rather than a change in outlook.
Q4 2025 net revenue was $247.1 million, up 29.6%; Cortrophin Gel rose 87.6% to $111.4 million, while Brands fell 37.9% to $12.3 million
Q4 GAAP diluted EPS was $1.18 versus a loss of $0.55 a year earlier; adjusted non-GAAP diluted EPS was $2.33 versus $1.63
Full-year 2025 net revenue was $883.4 million, up 43.8%, with GAAP net income available to common shareholders of $77.2 million
2026 guidance reaffirmed: total net revenue $1,055 million to $1,115 million and adjusted non-GAAP diluted EPS $8.83 to $9.34
Carter's reported fourth-quarter fiscal 2025 net sales of $925 million, up 7.6% from a year earlier, but adjusted diluted EPS fell 20.5% to $1.90 as tariff costs and other expenses weighed on margins. For the full year, adjusted diluted EPS fell 40.3% to $3.47, and the company expects adjusted diluted EPS to decline by a low double-digit to mid-teens percentage in fiscal 2026, excluding potential benefits from recent tariff developments.
Q4 net sales $925 million vs. $860 million; GAAP diluted EPS $1.76 vs. $1.71; adjusted diluted EPS $1.90 vs. $2.39
Fiscal 2025 net sales $2.898 billion vs. $2.844 billion; GAAP diluted EPS $2.53 vs. $5.12
Fiscal 2026 outlook: low double-digit to mid-teens decline in adjusted diluted EPS from $3.47; operating cash flow of $110 million to $120 million
Quarterly dividend of $0.25 per share declared February 19, 2026, payable March 27, 2026 to holders of record on March 13, 2026
Amneal Pharmaceuticals reported fourth-quarter 2025 net revenue of $814 million, up 11% from a year earlier, and GAAP net income attributable to the company of $35 million, compared with a loss of $31 million in the fourth quarter of 2024. For the full year, revenue rose 8% to $3.02 billion and adjusted diluted EPS was $0.83, and the company gave 2026 guidance of $3.05 billion to $3.15 billion in net revenue and $0.93 to $1.03 in adjusted diluted EPS, which is above 2025 results.
Q4 2025 net revenue was $814 million, up 11%, with Specialty up 38% and Affordable Medicines down 1%
Q4 2025 GAAP diluted EPS was $0.11 versus a loss of $0.10 a year earlier; adjusted diluted EPS was $0.21 versus $0.12
Full year 2025 net revenue was $3.02 billion and adjusted EBITDA was $688 million, up 10%
2026 guidance: net revenue of $3.05 billion to $3.15 billion, adjusted EBITDA of $720 million to $760 million, adjusted diluted EPS of $0.93 to $1.03
BrightSpring reported fourth-quarter 2025 revenue of $3,551 million, up 29.3%, and net income from continuing operations of $49.6 million, up from $4.3 million a year earlier. The company also initiated full-year 2026 revenue guidance of $14,450 million to $15,000 million and Adjusted EBITDA guidance of $760 million to $790 million, both excluding the Community Living business.
Q4 2025 Adjusted EBITDA was $184 million, up 40.7% from $130 million; full-year 2025 Adjusted EBITDA was $618 million, up 34.2%.
Full-year 2025 net income from continuing operations was $104.8 million, compared with a net loss of $68.9 million in 2024.
Leverage fell to 2.99x at December 31, 2025, from 4.16x a year earlier.
The Community Living divestiture to Sevita is expected to close by the end of the first quarter of 2026.
NW Natural Holdings reported full-year 2025 GAAP EPS of $2.77, up from $2.03, and adjusted EPS of $2.93, up from $2.33. For the fourth quarter, GAAP EPS rose to $1.39 from $1.12, while adjusted EPS was $1.39 versus $1.41 a year earlier. The company set 2026 EPS guidance of $2.95–3.15 and announced the MX3 Mist gas storage expansion, which is expected to cost about $300 million.
Full-year 2025 GAAP net income was $113.3 million ($2.77 per share), up from $78.9 million ($2.03 per share) in 2024.
Fourth-quarter 2025 GAAP net income was $57.8 million ($1.39 per share), up from $45.0 million ($1.12 per share); adjusted EPS was $1.39 versus $1.41.
2026 EPS guidance is $2.95–3.15; the company targets 4.0–6.0% long-term EPS growth through 2030.
MX3 storage expansion is expected to cost about $300 million and be in service by the end of 2029; the company declared a quarterly dividend of $0.4925 per share.
Arlo Technologies reported fourth-quarter and full-year 2025 results on February 26, 2026, with Q4 revenue of $141.3 million, up from $121.6 million a year earlier, and a GAAP profit of $0.05 per share compared with a loss of $0.05. The company also gave first-quarter 2026 revenue guidance of $135 million to $145 million and non-GAAP EPS guidance of $0.17 to $0.23, and said it has a partnership with Comcast for connected home security.
Q4 2025 revenue of $141.3 million, versus $121.6 million in Q4 2024
Q4 2025 GAAP EPS of $0.05 versus a loss of $0.05 in Q4 2024; full-year GAAP EPS of $0.14 versus a loss of $0.31 in 2024
Full-year 2025 revenue of $529.3 million, versus $510.9 million in 2024
Q1 2026 guidance: GAAP revenue of $135 million to $145 million; non-GAAP diluted EPS of $0.17 to $0.23
Concentra reported fourth-quarter 2025 revenue of $539.1 million, up 15.9%, and net income attributable to the Company of $34.7 million, up 61.2%. For full-year 2025, revenue rose 13.9% to $2,163.4 million, while net income attributable to the Company was flat at $166.4 million and EPS fell to $1.30 from $1.46. The company also gave 2026 guidance of $2.25 billion to $2.35 billion in revenue and declared a $0.0625 per share dividend.
Q4 2025 EPS was $0.27 versus $0.17 in Q4 2024; Adjusted EBITDA was $95.3 million, up 22.9%.
Full-year 2025 EPS was $1.30 versus $1.46 in 2024; full-year net income attributable to the Company was $166.4 million, down 0.1%.
2026 guidance: revenue of $2.25 billion to $2.35 billion and Adjusted EBITDA of $450 million to $470 million.
Board declared a $0.0625 per share dividend, payable on or about March 19, 2026, to holders of record on March 12, 2026.
Amphastar reported fourth-quarter and full-year 2025 results on February 26, 2026. Revenue, GAAP net income and diluted EPS declined from 2024 in both periods, and the release does not include financial guidance for 2026. Full-year results include a $23.1 million litigation provision, and glucagon sales fell 45% in the fourth quarter on lower average selling prices and unit volumes.
Q4 2025 net revenues were $183.1 million, down 2% from $186.5 million in Q4 2024
Q4 GAAP diluted EPS was $0.51 vs. $0.74; adjusted non-GAAP diluted EPS was $0.73 vs. $0.92
Full-year 2025 net revenues were $719.9 million vs. $732.0 million; GAAP diluted EPS was $2.03 vs. $3.06
BAQSIMI sales rose 46% to $185.4 million for the full year, while glucagon sales fell 36% to $69.1 million
Monster Beverage reported fourth-quarter and full-year 2025 results on February 26, 2026, with net sales, net income and diluted earnings per share all higher than in 2024. The company also named new regional leaders and said no shares were repurchased in the fourth quarter, leaving about $500.0 million available under its buyback program.
Q4 2025 net income rose 65.9% to $449.2 million, and diluted EPS rose to $0.46 from $0.28 a year earlier.
Full-year 2025 net sales rose 10.7% to $8.29 billion, and diluted EPS rose to $1.94 from $1.49.
Effective February 25, 2026, Rob Gehring became CEO, Americas, Guy Carling became CEO, EMEA & OSP, and Emelie Tirre became Chief Strategy Officer.
No shares were repurchased in Q4 2025; about $500.0 million remained available under the existing repurchase program as of February 26, 2026.
MARA Holdings reported preliminary, unaudited results for the fourth quarter and full year 2025, showing revenue down 6% in the quarter and a net loss of $1.7 billion, compared with net income of $528.3 million a year earlier. The company attributed the swing mainly to a $1.5 billion loss on fair value of digital assets as bitcoin prices fell, and it also announced a joint venture with Starwood Digital Ventures to develop AI and high-performance compute infrastructure. Final figures will come in the Form 10-K, so the reported numbers could change.
Q4 2025 revenue fell 6% to $202.3 million from $214.4 million in Q4 2024, driven by a 14% decrease in the average bitcoin price.
Q4 2025 net loss was $1.7 billion, or $4.52 per diluted share, versus net income of $528.3 million, or $1.24 per diluted share, in Q4 2024.
Full-year 2025 revenue rose 38% to $907.1 million, while the full-year net loss was $1.3 billion compared with net income of $541.0 million in 2024.
Adjusted EBITDA was a loss of $1.5 billion in Q4 2025 versus $796.0 million in Q4 2024; results remain preliminary and unaudited.
MasTec reported fourth quarter 2025 revenue of $3.9 billion, up 16% year over year, and GAAP diluted EPS of $1.81 versus $0.95 a year earlier. The company also issued initial guidance for 2026 of $17.0 billion in revenue and $8.40 in adjusted diluted EPS, compared with $6.55 in 2025, so shareholders get a forecast of continued growth.
Q4 2025 revenue was $3.9 billion, up 15.8% from $3.4 billion; GAAP net income was $153 million versus $85 million
Full-year 2025 revenue was $14.3 billion and GAAP net income was $422 million, both up from 2024
2026 guidance: revenue of $17.0 billion and adjusted EBITDA of $1.45 billion for the full year
Q1 2026 guidance: revenue of $3.475 billion and adjusted diluted EPS of $1.00
Arcosa reported fourth-quarter 2025 net income of $52.1 million, compared with a net loss of $7.7 million a year earlier, and full-year 2025 revenue of $2.88 billion, up 12%. The company also guided to 2026 revenue of $2.95 billion to $3.10 billion and adjusted EBITDA of $590 million to $640 million, excluding its planned $450 million sale of the barge business, which is expected to close in the second quarter of 2026.
Q4 2025 net income was $52.1 million, or $1.06 diluted EPS, versus a net loss of $7.7 million, or $(0.16) per share, in Q4 2024.
Full-year 2025 revenue was $2.88 billion, up 12%, and adjusted EBITDA was $583.3 million, up 30%.
2026 guidance: revenue of $2.95 billion to $3.10 billion and adjusted EBITDA of $590 million to $640 million, excluding the barge divestiture.
Barge business (Arcosa Marine Products) to be sold to Wynnchurch Capital L.P. for $450 million in cash, expected to close in Q2 2026; Group President Jesse E. Collins Jr. retires effective April 3, 2026.
Assured Guaranty reported fourth quarter 2025 net income attributable to the company of $119 million, or $2.53 per diluted share, up from $18 million, or $0.35 per share, a year earlier. For full year 2025, net income was $503 million, or $10.26 per share, compared with $376 million, or $6.87 per share, in 2024. The company also reported that it returned $500 million to shareholders through share repurchases in 2025.
Q4 2025 adjusted operating income was $109 million, or $2.32 per share, versus $66 million, or $1.27 per share, in Q4 2024.
FY 2025 adjusted operating income was $445 million, or $9.08 per share, versus $389 million, or $7.10 per share, in FY 2024.
Q4 2025 gross written premiums were $61 million, down from $186 million in Q4 2024; FY 2025 gross written premiums were $256 million, down from $440 million.
Shareholders' equity attributable to the company was $125.32 per share as of December 31, 2025, up from $108.80 a year earlier.
American Healthcare REIT reported fourth quarter and full year 2025 results on February 26, 2026, showing a swing to net income from prior-year losses and higher Normalized FFO per diluted share. The company also issued 2026 guidance for Normalized FFO of $1.99 to $2.05 per diluted share, with a $2.02 midpoint, compared with $1.72 in 2025. The guidance does not assume any transactions or capital markets activity beyond those already completed.
Q4 2025 GAAP net income attributable to controlling interest was $10.8 million, or $0.06 per diluted share, versus a loss of $31.8 million, or $0.21 per share, in Q4 2024.
Full-year 2025 GAAP net income attributable to controlling interest was $69.8 million, or $0.42 per diluted share, versus a loss of $37.8 million, or $0.29 per share, in 2024.
Normalized FFO was $0.46 per diluted share in Q4 2025 versus $0.40 a year earlier, and $1.72 for 2025 versus $1.41 in 2024; total portfolio same-store NOI grew 11.8% in Q4 and 14.2% for the year.
2026 guidance calls for net income of $0.75 to $0.81 per diluted share and total portfolio same-store NOI growth of 7.0% to 11.0%.
Tutor Perini reported fourth-quarter and full-year 2025 results in a press release furnished as Exhibit 99.1 to a Form 8-K dated February 26, 2026. Full-year revenue rose 28% to $5.5 billion, and the company returned to a profit after a loss in 2024, with diluted EPS of $1.51 compared with a loss of $3.13. The company also gave 2026 adjusted EPS guidance of $4.90 to $5.30, which excludes share-based compensation expense.
2025 revenue was $5.5 billion, up 28% from 2024.
Income from construction operations was $232.0 million in 2025, compared with a loss of $103.8 million in 2024.
Operating cash flow was a record $748.1 million in 2025, up 49% year-over-year.
The company expects 2026 adjusted EPS of $4.90 to $5.30 and does not provide GAAP EPS guidance.
SBA Communications reported fourth-quarter 2025 results, with net income of $370.4 million ($3.47 per diluted share) versus $178.8 million a year earlier, though that figure includes a $226.3 million gain on the sale of its Canadian operations. AFFO per share fell 8.1% to $3.19, and the company issued initial 2026 guidance that excludes all contracted EchoStar revenue while declaring a dividend of $1.25 per share, up about 13%.
Q4 2025 site leasing revenue rose 3.1% to $666.2 million; net income was $370.4 million, or $3.47 per diluted share, versus $1.61 a year earlier.
AFFO fell 9.2% to $340.4 million, and AFFO per share fell 8.1% to $3.19 from $3.47.
2026 outlook projects total revenues of $2,815.0 million to $2,860.0 million and AFFO per share of $11.84 to $12.29, excluding all contracted EchoStar revenue.
Quarterly dividend of $1.25 per share is payable March 27, 2026, to holders of record on March 13, 2026.
DoubleVerify reported fourth-quarter and full-year 2025 results, with full-year revenue up 14% to $748.3 million but net income down to $50.7 million from $56.2 million in 2024. The Board also approved a $300 million share repurchase program that replaces the November 2024 program, and the company guided 2026 revenue growth of 8% to 10%.
Full-year 2025 revenue of $748.3 million, up 14%; net income of $50.7 million versus $56.2 million in 2024, and diluted EPS of $0.30 versus $0.32.
Fourth-quarter 2025 revenue of $205.6 million, up 8%, with net income of $29.3 million.
2026 guidance: full-year revenue of $810 million to $826 million, up 8% to 10%, and adjusted EBITDA margin of about 34%.
Board approved a $300 million repurchase program, replacing the November 2024 program; it has no time limit and does not obligate the company to buy a specific number of shares.
Dentsply Sirona reported a fourth quarter and full-year 2025 net loss, with fourth-quarter net sales up 6.2% but full-year net sales down 3.0%. The company also eliminated its quarterly dividend, announced a restructuring plan, and set 2026 net sales and adjusted EPS outlooks below its 2025 adjusted EPS of $1.60, which matters to shareholders because the dividend is gone and the outlook implies lower per-share earnings.
Q4 2025 net sales were $961 million, up 6.2%, but the company posted a net loss of $146 million, or $0.74 per diluted share, driven by $144 million in net-of-tax goodwill and intangible impairments.
FY 2025 net sales were $3,680 million, down 3.0%, and the net loss was $598 million, or $3.00 per diluted share, compared with a $910 million loss in 2024.
FY 2026 outlook: net sales of $3.5 billion to $3.6 billion and adjusted EPS of $1.40 to $1.50, versus FY 2025 adjusted EPS of $1.60.
The Board eliminated the quarterly cash dividend, which the company said will redirect capital to debt retirement and share repurchases; a restructuring plan carries $55 million to $65 million in charges and about $120 million in annualized
National Health Investors reported fourth quarter 2025 results and introduced 2026 annual guidance. Diluted earnings per share fell to $0.80 from $0.95 a year earlier, while normalized FFO per diluted share rose to $1.22 from $1.12, and the company projects 2026 normalized FFO per diluted share of $4.94 to $4.99.
Q4 2025 diluted EPS was $0.80 versus $0.95 in Q4 2024; NAREIT FFO per diluted share was $1.22 versus $1.24.
Full-year 2025 normalized FFO per diluted share was $4.91 versus $4.44 in 2024; diluted EPS was $3.02 versus $3.13.
2026 guidance: normalized FFO per diluted share of $4.94 to $4.99 and normalized FAD of $248.9 million to $251.4 million.
As of December 31, 2025, net debt was $1.2 billion and net debt to adjusted EBITDA was 3.8x.
Rocket Lab reported fourth-quarter 2025 revenue of $179.7 million, up from $132.4 million a year earlier, and full-year revenue of $601.8 million, up from $436.2 million. The company also guided to first-quarter 2026 revenue of $185 million to $200 million, but its net loss widened for the full year to $198.2 million from $190.2 million.
Q4 2025 revenue $179.7 million vs $132.4 million in Q4 2024; net loss $52.9 million, or $0.09 per share, vs $52.3 million, or $0.10 per share
Full-year 2025 revenue $601.8 million vs $436.2 million in 2024; net loss $198.2 million, or $0.37 per share
Q1 2026 guidance: revenue $185 million to $200 million; adjusted EBITDA loss $21 million to $27 million
Backlog reached $1.85 billion at year-end, up 73% year on year; Neutron first launch now targeted for Q4 2026
Dell reported record fiscal 2026 fourth-quarter revenue of $33.4 billion, up 39%, and record full-year revenue of $113.5 billion, up 19%. It guided fiscal 2027 revenue to $138.0 billion to $142.0 billion, and it raised its cash dividend by 20% and its share repurchase authorization by $10 billion.
Q4 FY26 revenue of $33.4 billion, up 39%; diluted EPS of $3.37, up 57%
FY26 revenue of $113.5 billion, up 19%; diluted EPS of $8.68, up 36%
FY27 revenue guidance of $138.0 billion to $142.0 billion; GAAP diluted EPS midpoint of $11.52
Strategic Education reported fourth quarter 2025 revenue of $323.2 million, up 3.8%, and diluted earnings per share of $1.66 compared with $1.05 a year earlier. For full-year 2025, revenue rose 4.0% to $1,268.2 million and diluted EPS was $5.41 versus $4.67, with the company also declaring a $0.60 quarterly dividend for shareholders of record as of March 9, 2026.
Q4 2025 income from operations was $51.6 million, or 16.0% of revenue, versus $36.0 million, or 11.6%, in Q4 2024
Full-year 2025 net income was $126.6 million, compared with $112.7 million in 2024, and the company repurchased shares for $138.9 million during the year
Quarterly cash dividend of $0.60 per share, payable March 16, 2026
The filing does not include financial guidance for 2026
Brink's reported fourth-quarter 2025 revenue of $1,379 million, up 9% (5% organic), and GAAP earnings per share of $1.62, up 93%. For full-year 2025, revenue reached $5,261 million (up 5%) and GAAP EPS was $4.70 (up 30%), and the company gave first-quarter 2026 non-GAAP guidance and a 2026 framework.
Q4 2025 operating profit was $180 million on a GAAP basis, up 72%, and non-GAAP EPS was $2.54, up 20%.
Full-year 2025 adjusted EBITDA was $977 million, up 7%, with operating cash flow of $640 million and free cash flow of $436 million.
Q1 2026 non-GAAP guidance calls for revenue of $1,335 million to $1,395 million, adjusted EBITDA of $220 million to $240 million, and EPS of $1.50 to $1.90.
Net debt leverage fell to 2.7 times adjusted EBITDA, and the company returned over $250 million to shareholders through dividends and share repurchases.
Fox Factory reported fourth-quarter fiscal 2025 net sales of $361.1 million, up 2.3%, but posted a net loss of $287.0 million, or $6.86 per diluted share, driven mainly by goodwill impairment. Adjusted EBITDA fell to $35.0 million from $40.4 million, and the company launched a Phase 2 profit plan and introduced fiscal 2026 guidance for adjusted EBITDA of $174 million to $203 million.
Q4 net sales rose 2.3% to $361.1 million; net loss was $287.0 million, or $6.86 per diluted share, versus a $0.1 million loss a year earlier.
Adjusted EPS was $0.20 versus $0.31 in the prior-year quarter; adjusted EBITDA was $35.0 million versus $40.4 million.
Full-year fiscal 2025 goodwill impairment was $557.3 million; goodwill fell to $83.6 million from $639.5 million.
Phase 2 targets about $40 million in additional savings in 2026; fiscal 2026 net sales guidance is $1.328 billion to $1.416 billion, and the company expects to divest its Phoenix, Arizona AAG operations by the end of Q1 fiscal 2026.
Solventum reported fourth-quarter 2025 net sales of $1,998 million, down 3.7% on a reported basis but up 3.5% organically, and introduced 2026 full-year guidance. Adjusted diluted EPS rose to $1.57 from $1.41, while the company guided to 2026 adjusted EPS of $6.40 to $6.60, compared with $6.11 for full-year 2025.
Q4 2025 reported net sales of $1,998 million, down 3.7%; organic sales up 3.5%
Q4 2025 GAAP diluted EPS of $0.36 versus $0.17; adjusted diluted EPS of $1.57 versus $1.41
2026 guidance: organic sales growth of 2.0% to 3.0%, adjusted EPS of $6.40 to $6.60, and free cash flow of about $200 million
Full-year 2025 free cash flow was negative $10 million and adjusted EPS was $6.11, down 8.8%
Sunrun reported fourth-quarter 2025 revenue of $1,158.8 million, up 124% from a year earlier, and net income attributable to common stockholders of $103.6 million, compared with a loss of $2.81 billion a year earlier that included a $3.1 billion goodwill impairment. However, the company's Contracted Net Value Creation fell 44% to $176 million, and it gave full-year 2026 guidance for Contracted Net Value Creation of $650 million to $1.05 billion and Cash Generation of $250 million to $450 million.
Q4 2025 total revenue was $1,158.8 million, up $640.3 million, or 124%, driven partly by a third-quarter 2025 transaction in which certain systems were sold to a third party.
Q4 2025 net income attributable to common stockholders was $103.6 million ($0.38 per diluted share), versus a loss of $2,813.7 million in Q4 2024.
Contracted Net Value Creation was $176 million in Q4 2025, down 44%, and Subscriber Additions were 25,475, down 17%.
For full-year 2026, Sunrun expects Aggregate Subscriber Value of $4.8 billion to $5.2 billion and Contracted Net Value Creation of $650 million to $1.05 billion.
BioLife Solutions reported fourth quarter and full year 2025 results and introduced 2026 guidance of $112.5 million to $115.0 million in revenue, up 17% to 20%. Revenue grew in both periods and the company returned to a quarterly net profit from continuing operations, but the full-year loss from continuing operations widened to $12.1 million from $8.8 million, including a $15.5 million in-process R&D expense.
Q4 2025 revenue from continuing operations was $24.8 million, up 20% from $20.7 million; full-year revenue was $96.2 million, up 29%.
Q4 2025 GAAP net income from continuing operations was $2.1 million, or $0.04 per share, compared with a $1.2 million loss in Q4 2024.
Full-year 2025 GAAP net loss from continuing operations was $12.1 million, compared with $8.8 million in 2024; adjusted EBITDA was $25.0 million, or 26% of revenue.
The company completed the sale of evo on October 6, 2025, for $25.5 million in cash; cash, equivalents and marketable securities were $120.2 million at December 31, 2025.
Talen Energy reported a full-year 2025 GAAP net loss attributable to stockholders of $219 million, compared with net income of $998 million in 2024. The loss reflects a $501 million fourth-quarter charge tied to a change in accounting for certain stock-based awards, while Adjusted EBITDA rose to $1,035 million from $770 million and Adjusted Free Cash Flow reached $524 million. The company reaffirmed its 2026 guidance of $1,750 million to $2,050 million in Adjusted EBITDA, which excludes the pending Cornerstone Acquisition.
Full-year 2025 GAAP net loss attributable to stockholders was $219 million, versus net income of $998 million in 2024.
Full-year 2025 Adjusted EBITDA was $1,035 million, up from $770 million, and Adjusted Free Cash Flow was $524 million, up from $283 million.
The company reaffirmed 2026 Adjusted EBITDA guidance of $1,750 million to $2,050 million and Adjusted Free Cash Flow guidance of $980 million to $1,180 million.
Talen signed a definitive agreement on January 15, 2026 for the Cornerstone Acquisition, with a purchase price of $3.45 billion, expected to close early in the second half of 2026.
DiamondRock Hospitality reported fourth quarter and full year 2025 results. Q4 net income attributable to common stockholders was $23.8 million, or $0.12 per diluted share, compared with a loss of $13.7 million a year earlier, and Adjusted FFO per diluted share rose 12.5% to $0.27. The company also issued 2026 guidance of $287 million to $302 million in Adjusted EBITDA and $1.09 to $1.16 in Adjusted FFO per share, against 2025 Adjusted EBITDA of $297.6 million.
Q4 2025 Adjusted EBITDA was $71.9 million, up 3.3%, and comparable RevPAR fell 0.3% to $201.83
Full year 2025 Adjusted FFO per diluted share was $1.08, up 3.8%, and full year net income attributable to common stockholders was $91.6 million, or $0.44 per diluted share
2026 guidance: Adjusted EBITDA $287 million to $302 million and Adjusted FFO per share $1.09 to $1.16, versus 2025 actuals of $297.6 million and $1.08
Preferred stock redeemed December 31, 2025 for $121.5 million; regular quarterly dividend of $0.09 per share payable April 14, 2026
Evertec reported preliminary fourth-quarter 2025 results, with revenue up 13.1% but GAAP net income attributable to common shareholders down 11.2%, driven by higher depreciation, amortization, cost of revenues and personnel expenses. Full-year 2025 revenue rose 10.2% and GAAP net income rose 25.7%, and the board raised the share repurchase authorization to $150 million through December 31, 2027, with about $84.4 million remaining before the increase.
Q4 2025 revenue was $244.8 million, up 13.1% from $216.4 million; GAAP net income attributable to common shareholders was $35.6 million, or $0.56 per diluted share, down 11.2%.
Full-year 2025 revenue was $931.8 million, up 10.2%; GAAP net income was $141.6 million, or $2.20 per diluted share, up 25.7%.
On February 25, 2026, the board approved raising the share repurchase authorization to $150 million through December 31, 2027.
The revised 2026 outlook calls for total revenue of $1,024 million to $1,036 million and adjusted earnings per share of $3.84 to $3.96.
Autodesk reported fourth-quarter fiscal 2026 revenue of $1.96 billion, up 19% from a year earlier, and GAAP diluted earnings of $1.48 per share, up from $1.40. The company also issued fiscal 2027 guidance for revenue of $8.100 billion to $8.170 billion and GAAP diluted EPS of $7.76 to $8.39, and said it expects temporary risk to billings and revenue as it rolls out a sales optimization plan.
Q4 fiscal 2026 revenue was $1,957 million, up 19%, and non-GAAP diluted EPS was $2.85, up from $2.29
Restructuring, other exit costs, and facility reductions were $100 million in Q4, up from $15 million a year earlier
Fiscal 2027 guidance: revenue $8,100 million to $8,170 million, free cash flow $2,700 million to $2,800 million
First-quarter fiscal 2027 revenue guidance is $1,885 million to $1,900 million
CoreWeave reported fourth-quarter and full-year 2025 results, with revenue up sharply from a year earlier. The net loss also widened substantially, and the company reported a revenue backlog of $66.8 billion as of December 31, 2025. The company said it will give forward-looking guidance on its earnings call, so shareholders will not see guidance in this filing.
Q4 2025 revenue was $1,572 million, compared with $747 million in Q4 2024.
Q4 2025 net loss was $452 million, or $0.89 per share, compared with a net loss of $51 million, or $0.34 per share, a year earlier.
Full-year 2025 revenue was $5,131 million, compared with $1,915 million in 2024, and full-year net loss was $1,167 million.
Revenue backlog was $66.8 billion as of December 31, 2025; the company will provide guidance on its earnings call.
NetApp reported third-quarter fiscal 2026 results for the quarter ended January 23, 2026, with net revenues of $1.71 billion, up 4% year over year, and GAAP diluted earnings per share of $1.67, up from $1.44. The company also guided fourth-quarter net revenues to $1.795 billion to $1.945 billion and full-year fiscal 2026 GAAP EPS to $6.07 to $6.17, which matters to shareholders because it sets the company's near-term financial expectations.
Net revenues were $1.71 billion, up 4% from $1.64 billion; billings were $1.89 billion, up 10%.
GAAP diluted EPS was $1.67 versus $1.44 a year earlier; non-GAAP diluted EPS was $2.12 versus $1.91.
Fourth-quarter fiscal 2026 net revenue guidance is $1.795 billion to $1.945 billion, with GAAP EPS of $1.76 to $1.86.
Cash provided by operations was $317 million, down 18% from $385 million; the company returned $303 million to stockholders.
Progyny reported fourth-quarter 2025 revenue of $318.4 million, up 6.7%, and full-year revenue of $1,288.7 million, up 10%. Full-year diluted earnings per share rose to $0.65 from $0.57, and the company issued 2026 guidance for revenue of $1.355 billion to $1.405 billion and net income of $95.4 million to $106.1 million. The Q1 2026 revenue outlook of (1.6)% to 2.5% growth signals modest near-term growth.
Q4 2025 revenue was $318.4 million, up from $298.4 million; a large client that did not renew contributed $35.9 million in Q4 2024 and none in Q4 2025.
Full-year 2025 net income was $58.5 million, or $0.65 per diluted share, versus $54.3 million, or $0.57, in 2024.
2026 outlook: revenue of $1.355 billion to $1.405 billion and net income of $95.4 million to $106.1 million.
Q1 2026 revenue is projected at $319.0 million to $332.0 million, growth of (1.6)% to 2.5%.
MP Materials reported fourth-quarter 2025 net income of $9.4 million, compared with a net loss of $22.3 million a year earlier, while revenue fell 14% to $52.7 million. The quarter was lifted by $51.0 million of price protection agreement income tied to the U.S. Department of War's NdPr price floor, which began October 1, 2025, and by the company's cessation of rare earth concentrate sales to China. For full year 2025, revenue rose 10% to $224.4 million, but the net loss widened to $85.9 million from $65.4 million.
Q4 2025 revenue of $52.7 million, down 14% year over year; diluted EPS of $0.05 versus $(0.14) in Q4 2024
Q4 2025 Adjusted EBITDA of $39.2 million versus $(10.7) million a year earlier, including $51.0 million of price protection agreement income
Full year 2025 revenue of $224.4 million, up 10%; net loss of $85.9 million; diluted EPS of $(0.50) versus $(0.57) in 2024
The filing contains no forward revenue or earnings guidance; the release says the company expects to break ground on its Northlake, Texas 10X magnetics facility in 2026
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.